118 related articles for article (PubMed ID: 18628278)
1. Carotid intima-media thickness (cIMT): a useful clinic tool or research luxury? Another view of the ENHANCE trial.
Toutouzas P; Richter D
Angiology; 2008; 59(2 Suppl):77S-9S. PubMed ID: 18628278
[TBL] [Abstract][Full Text] [Related]
2. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
Blake JA
N Engl J Med; 2008 Jul; 359(5):531; author reply 532-3. PubMed ID: 18677798
[No Abstract] [Full Text] [Related]
3. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
Kastelein JJ; Akdim F; Stroes ES; Zwinderman AH; Bots ML; Stalenhoef AF; Visseren FL; Sijbrands EJ; Trip MD; Stein EA; Gaudet D; Duivenvoorden R; Veltri EP; Marais AD; de Groot E;
N Engl J Med; 2008 Apr; 358(14):1431-43. PubMed ID: 18376000
[TBL] [Abstract][Full Text] [Related]
4. Making sense of ENHANCE: ezetimibe (Zetia) lowers LDL cholesterol but doesn't decrease carotid intima-media thickness.
Smith D
Mt Sinai J Med; 2008; 75(2):143-7. PubMed ID: 18500716
[No Abstract] [Full Text] [Related]
5. Comparison of ezetimibe plus simvastatin versus simvastatin monotherapy on atherosclerosis progression in familial hypercholesterolemia. Design and rationale of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression (ENHANCE) trial.
Kastelein JJ; Sager PT; de Groot E; Veltri E
Am Heart J; 2005 Feb; 149(2):234-9. PubMed ID: 15846260
[TBL] [Abstract][Full Text] [Related]
6. The role of ezetimibe in the prevention of cardiovascular disease: where do we stand after ARBITER 6-HALTS.
Howard WJ
Nutr Metab Cardiovasc Dis; 2010 Jun; 20(5):295-300. PubMed ID: 20556890
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
Eichhorn EJ
N Engl J Med; 2008 Jul; 359(5):529-30; author reply 532. PubMed ID: 18677795
[No Abstract] [Full Text] [Related]
8. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
Connor WE
N Engl J Med; 2008 Jul; 359(5):530; author reply 532-3. PubMed ID: 18677797
[No Abstract] [Full Text] [Related]
9. Does ENHANCE diminish confidence in lowering LDL or in ezetimibe?
Brown BG; Taylor AJ
N Engl J Med; 2008 Apr; 358(14):1504-7. PubMed ID: 18376002
[No Abstract] [Full Text] [Related]
10. Statin therapy with ezetimibe or niacin in high-risk patients.
Kastelein JJ; Bots ML
N Engl J Med; 2009 Nov; 361(22):2180-3. PubMed ID: 19915218
[No Abstract] [Full Text] [Related]
11. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
Diamond GA; Kaul S
N Engl J Med; 2008 Jul; 359(5):530; author reply 532. PubMed ID: 18677796
[No Abstract] [Full Text] [Related]
12. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
Steinberg D
N Engl J Med; 2008 Jul; 359(5):529; author reply 532. PubMed ID: 18669434
[No Abstract] [Full Text] [Related]
13. The VYtorin on Carotid intima-media thickness and overall arterial rigidity (VYCTOR) study.
Meaney A; Ceballos G; Asbun J; Solache G; Mendoza E; Vela A; Meaney E
J Clin Pharmacol; 2009 Jul; 49(7):838-47. PubMed ID: 19443679
[TBL] [Abstract][Full Text] [Related]
14. Extended-release niacin or ezetimibe and carotid intima-media thickness.
Taylor AJ; Villines TC; Stanek EJ; Devine PJ; Griffen L; Miller M; Weissman NJ; Turco M
N Engl J Med; 2009 Nov; 361(22):2113-22. PubMed ID: 19915217
[TBL] [Abstract][Full Text] [Related]
15. Cholesterol absorption inhibitors in the treatment of hyperlipidemia: clinical outcomes in large clinical trials.
Kesäniemi A
Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():29-30. PubMed ID: 18001318
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol lowering and ezetimibe.
Drazen JM; Jarcho JA; Morrissey S; Curfman GD
N Engl J Med; 2008 Apr; 358(14):1507-8. PubMed ID: 18376001
[No Abstract] [Full Text] [Related]
17. A pilot randomized trial comparing an intensive versus a standard intervention in stable HIV-infected patients with moderate-high cardiovascular risk.
Masiá M; Bernal E; Padilla S; García N; Escribano JC; Martínez E; Gutiérrez F
J Antimicrob Chemother; 2009 Sep; 64(3):589-98. PubMed ID: 19625372
[TBL] [Abstract][Full Text] [Related]
18. Subclinical atherosclerosis: evolving role of carotid intima-media thickness.
Mookadam F; Moustafa SE; Lester SJ; Warsame T
Prev Cardiol; 2010; 13(4):186-97. PubMed ID: 20860643
[TBL] [Abstract][Full Text] [Related]
19. Additional lipid lowering trials using surrogate measurements of atherosclerosis by carotid intima-media thickness: more clarity or confusion?
Stein EA
J Am Coll Cardiol; 2008 Dec; 52(25):2206-9. PubMed ID: 19095140
[No Abstract] [Full Text] [Related]
20. Biomarkers and surrogate endpoints in cardiovascular therapeutics research: under scrutiny following results of the ENHANCE Study.
Pauriah M; Struthers AD; Lang CC
Cardiovasc Ther; 2008; 26(2):85-8. PubMed ID: 18485130
[No Abstract] [Full Text] [Related]
[Next] [New Search]
